Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. (2014)

First Author: Abbasi A
Attributed to:  Aetiology of type 2 diabetes and related metabolic disorders funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00125-014-3278-9

PubMed Identifier: 24893865

Publication URI: http://europepmc.org/abstract/MED/24893865

Type: Journal Article/Review

Volume: 57

Parent Publication: Diabetologia

Issue: 9

ISSN: 0012-186X